We discuss the highlights for the CPM in 2024-25, and look forward to the next year.

The CPM team discuss considerations of equity in personalised medicine.

Rachel Horton and Sally Sansom from the CPM team discuss health economics with James Buchanan, Padraig Dixon and Sarah Wordsworth.

The CPM team discuss how interactions with healthcare systems are changing as health-relevant information becomes more accessible outside traditional clinical domains.

The CPM team discuss environmental sustainability in personalised medicine with Dr Gabrielle Samuel from King's College London.

The CPM team discuss the benefits and challenges of personalised prevention approaches with Dr Malte Gerhold from the Health Foundation.

The CPM team discuss what we mean when we talk about personalised medicine.

We discuss the highlights for the CPM in 2023-24, and look forward to the next year.

What might it be like to navigate a genetic diagnosis and share it with family members? We talk to Julie Young from the CanGene CanVar patient reference panel about her experience.

As a society, we tend to focus a lot on risk and try to control it through regulation - but how well does that work for ensuring ethical practice in genomics? We talk to Dr Kate Lyle about her research on this topic. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

What are the ethical challenges with diversifying genomic data? We talk to Faranak Hardcastle about her work exploring this.

We live our lives alongside others, and our decisions have consequences for those close to us - what does this mean for how we define 'the patient' in genomic medicine? Susie Weller talks to us about this issue.

What sort of findings might we get from newborn genome screening? What might this mean for the NHS? Rachel Horton talks to Gabby Samuel and Lisa Ballard.

Who does a genetic result belong to? What might help people to share genetic information with their relatives? We talk to Lisa Ballard and Anneke Lucassen.

How can the same genetic finding can mean different things in different people? What does this mean for 'personalising' genetic results? Anneke Lucassen talks to us about this issue. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

How does personalised medicine impact on the environment? What does this mean for how we should collect and store data? Gabrielle Samuel talks to us about these issues. A transcript of this episode is available at https://media.podcasts.ox.ac.uk/medsci/cpm/2022-06-15-medsci-cpm-s2-ep-1.pdf

In the second episode of the Meet the Advisory Board Series we talked to Dame Mary Archer about personalised medicine in practice, her academic career and her plethora of other roles she has held and is holding at the moment. This interview was created by the Centre for Personalised Medicine (CPM), a partnership between University of Oxford’s Wellcome Centre for Human Genetics (WHG) and St Anne’s College, Oxford. The CPM provides opportunities for students, academics, clinicians and the public to explore the benefits and challenges of Personalised Medicine. Visit our website: [http://www.cpm.well.ox.ac.uk

In the first episode of the Meet the Advisory Board Series we talked to Dr Magdalena Skipper to find out about her remarkable career in academia, science publishing and her views on personalised medicine. This interview was created by the Centre for Personalised Medicine (CPM), a partnership between University of Oxford’s Wellcome Centre for Human Genetics (WHG) and St Anne’s College, Oxford. The CPM provides opportunities for students, academics, clinicians and the public to explore the benefits and challenges of Personalised Medicine. Visit our website: http://www.cpm.well.ox.ac.uk for a transcript of the episode, more information and upcoming events, and follow us @CPMOxford